1
|
Dubey L, Dorosh O, Dubey N, Doan S, Kozishkurt O, Duzenko O, Kozlova O, Ievtukh V, Ladny JR, Pruc M, Szarpak L, Pukach J. COVID-19-induced coagulopathy: Experience, achievements, prospects. Cardiol J 2023:VM/OJS/J/92002. [PMID: 36588310 DOI: 10.5603/cj.a2022.0123] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/25/2022] [Revised: 10/09/2022] [Accepted: 10/09/2022] [Indexed: 01/03/2023] Open
Abstract
The presence of coagulopathy as part of the systemic inflammatory response syndrome is a characteristic feature of severe coronavirus disease 2019 (COVID-19). Hematological changes (increased DD-dimer, prolonged activated partial thromboplastin clotting time [APTT] and prothrombin time [PT], high fibrinogen levels) have been observed in hospitalized patients with COVID-19, which characterize the risk of thrombotic events. Against the background of COVID-19 there is endothelial dysfunction, hypoxia and pulmonary congestion, mediated by thrombosis and microvascular occlusion. Up to 71.4% of patients who died from COVID-19 had disseminated intravascular coagulation syndrome, compared with only 0.6% of survivors. The main manifestation of COVID-19-associated coagulopathy is a significant increase in DD without a decrease in platelet count or prolongation of APTT and PT, indicating increased thrombin formation and the development of local fibrinolysis. An increase in DD levels of more than 3-4 times was associated with higher in-hospital mortality. Therefore, COVID-19 requires assessment of the severity of the disease for further tactics of thromboprophylaxis. The need for continued thromboprophylaxis, or therapeutic anticoagulation, in patients after inpatient treatment for two weeks using imaging techniques to assess of thrombosis assessment.
Collapse
Affiliation(s)
- Leonid Dubey
- Danylo Halytsky Lviv National Medical University, Lviv, Ukraine
| | - Olga Dorosh
- Danylo Halytsky Lviv National Medical University, Lviv, Ukraine.,ENT "Western Ukrainian Specialized Children's Medical Center", Lviv, Ukraine
| | - Nataliya Dubey
- Danylo Halytsky Lviv National Medical University, Lviv, Ukraine
| | - Svitlana Doan
- International European University, Kyiv, Ukraine.,National Medical University of Odessa, Ukraine
| | | | | | - Olena Kozlova
- Danylo Halytsky Lviv National Medical University, Lviv, Ukraine.,ENT "Western Ukrainian Specialized Children's Medical Center", Lviv, Ukraine
| | | | - Jerzy R Ladny
- Medical University of Bialystok, Poland.,Polish Society of Disaster Medicine, Warsaw, Poland
| | - Michal Pruc
- Polish Society of Disaster Medicine, Warsaw, Poland
| | | | - Julia Pukach
- Danylo Halytsky Lviv National Medical University, Lviv, Ukraine
| |
Collapse
|
2
|
Hallali G, Le HM, Souied E, Doan S. [Severe eyelid eczema secondary to intravenous obnituzumab treated successfully with tacrolimus cream: Case report]. J Fr Ophtalmol 2022; 45:e426-e427. [PMID: 35659427 DOI: 10.1016/j.jfo.2022.01.020] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/20/2022] [Revised: 01/21/2022] [Accepted: 01/26/2022] [Indexed: 11/27/2022]
Affiliation(s)
- G Hallali
- Service d'ophtalmologie, hôpital intercommunal Henri-Mondor, université Paris-Est Créteil (UPEC, Paris XII), 40, avenue de Verdun, 94000 Créteil, France; Service d'ophtalmologie, fondation Adolphe de Rothschild, 29, rue Manin, 75019 Paris, France.
| | - H M Le
- Service d'ophtalmologie, hôpital intercommunal Henri-Mondor, université Paris-Est Créteil (UPEC, Paris XII), 40, avenue de Verdun, 94000 Créteil, France
| | - E Souied
- Service d'ophtalmologie, hôpital intercommunal Henri-Mondor, université Paris-Est Créteil (UPEC, Paris XII), 40, avenue de Verdun, 94000 Créteil, France
| | - S Doan
- Service d'ophtalmologie, fondation Adolphe de Rothschild, 29, rue Manin, 75019 Paris, France
| |
Collapse
|
3
|
Doan S, Arnould L, Febvay C, Fournié P, Gueudry J, Labalette P, Ouilhon C, Tran THC, Vabres B, Barbarot S, Bouaziz JD, Du-Thanh A, Jachiet M, Seneschal J, Soria A, Staumont-Sallé D, Baudouin C, Mortemousque B. Blépharo-conjonctivites sous dupilumab : recommandations du groupe CEDRE. Dermatite atopique, conjonctivites et dupilumab : quelle prise en charge ? J Fr Ophtalmol 2022; 45:277-287. [DOI: 10.1016/j.jfo.2021.12.007] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/05/2021] [Accepted: 12/20/2021] [Indexed: 11/17/2022]
|
4
|
Bush A, Ferkol T, Valiulis A, Mazur A, Chkhaidze I, Maglakelidze T, Sargsyan S, Boyajyan G, Cirstea O, Doan S, Katilov O, Pokhylko V, Dubey L, Poluziorovienė E, Prokopčiuk N, Taminskienė V, Valiulis A. Unfriendly Fire: How the Tobacco Industry is Destroying the Future of Our Children. Acta Med Litu 2021; 28:6-18. [PMID: 34393624 PMCID: PMC8311841 DOI: 10.15388/amed.2020.28.1.6] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/27/2020] [Revised: 01/27/2021] [Accepted: 01/28/2021] [Indexed: 11/27/2022] Open
Abstract
Tobacco has long been known to be one of the greatest causes of morbidity and mortality in the adults, but the effects on the foetus and young children, which are lifelong, have been less well appreciated. Developing from this are electronic nicotine delivery systems or vapes, promulgated as being less harmful than tobacco. Nicotine itself is toxic to the foetus, with permanent effects on lung structure and function. Most vapes contain nicotine, but they also contain many other compounds which are inhaled and for which there are no toxicity studies. They also contain known toxic substances, whose use is banned by European Union legislation. Accelerating numbers of young people are vaping, and this does not reflect an exchange of vapes for cigarettes. The acute toxicity of e-cigarettes is greater than that of tobacco, and includes acute lung injury, pulmonary haemorrhage and eosinophilic and lipoid pneumonia. Given the worse acute toxicity, it should be impossible to be complacent about medium and long term effects of vaping. Laboratory studies have demonstrated changes in lung proteomics and the innate immune system with vaping, some but not all of which overlap with tobacco. It would be wrong to consider vapes as a weaker form of tobacco, they have their own toxicity. Children and young people are being targeted by the vaping industry (which is largely the same as the tobacco industry), including on-line, and unless an efficient legislative program is put in place, a whole new generation of nicotine addicts will result.
Collapse
Affiliation(s)
- Andrew Bush
- Imperial College Centre for Paediatrics and Child Health, London, UK
National Heart and Lung Institute, London, UK
Royal Brompton Harefield NHS Foundation Trust, London, UK
| | - Thomas Ferkol
- Washington University School of Medicine, St. Louis, Missouri, USA
| | - Algirdas Valiulis
- Vilnius University Medical Faculty Institute of Health Sciences, Vilnius, Lithuania
| | - Artur Mazur
- Medical College of Rzeszow University, Department of Pediatrics, Pediatric Endocrinology and Diabetes, Rzeszow, Poland
| | - Ivane Chkhaidze
- Tbilisi State Medical University, Department of Paediatrics, Tbilisi, Georgia
Iashvili Central Children’s Hospital, Tbilisi, Georgia
| | - Tamaz Maglakelidze
- Ivane Javakhishvili Tbilisi State University, Department of Pulmonology, Tbilisi, Georgia
Chapidze Emergency Cardiology Center, Tbilisi, Georgia Planning Committee of Global Initiative Against Chronic Respiratory Diseases (WHO GARD), Geneva, Switzerland
| | - Sergey Sargsyan
- Arabkir Medical Centre, Instutute of Child and Adolescent Health, Yerevan, Armenia
| | - Gevorg Boyajyan
- Arabkir Medical Centre, Instutute of Child and Adolescent Health, Yerevan, Armenia
| | - Olga Cirstea
- University of Medicine and Pharmacy “Nicolae Testemitanu”, Department of Paediatrics, Chisinau, Republic of Moldova
| | - Svitlana Doan
- Kyiv Medical University, Department of Public Health and Microbiology, Kyiv, Ukraine
| | | | - Valeriy Pokhylko
- Ukrainian Medical Stomatological Academy, Department of Paediatrics, Poltava, Ukraine
| | - Leonid Dubey
- Lviv National Medical University by Danylo Galytsky, Lviv, Ukraine
| | - Edita Poluziorovienė
- Vilnius University Medical Faculty Institute of Clinical Medicine, Vilnius, Lithuania
| | - Nina Prokopčiuk
- Vilnius University Medical Faculty Institute of Clinical Medicine, Vilnius, Lithuania
| | - Vaida Taminskienė
- Vilnius University Medical Faculty Institute of Health Sciences, Vilnius, Lithuania
| | - Arūnas Valiulis
- Vilnius University Medical Faculty Institute of Health Sciences, Vilnius, Lithuania
Vilnius University Medical Faculty Institute of Clinical Medicine, Vilnius, Lithuania
Planning Committee of Global Initiative Against Chronic Respiratory Diseases (WHO GARD), Geneva, Switzerland
| |
Collapse
|
5
|
Egri S, Van Hollebecke I, Guindolet D, Manenti C, Rougier H, Gabison É, Cochereau I, Doan S. [Efficacy of intense pulsed light therapy in the treatment of Meibomian gland dysfunction-related severe dry eye]. J Fr Ophtalmol 2021; 44:169-175. [PMID: 33358077 DOI: 10.1016/j.jfo.2020.04.061] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/05/2019] [Revised: 04/19/2020] [Accepted: 04/22/2020] [Indexed: 11/19/2022]
Abstract
INTRODUCTION Dry eye syndrome caused by Meibomian gland dysfunction (MGD) is a common disease in the general population and impairs quality of life. Intense Pulsed Light (IPL) has mainly been used in dermatology for the treatment of skin disorders, and more recently for MGD-related dry eye. The objective of our study is to evaluate the efficacy and tolerability of IPL with the E-Eye® device (E-Swin, Houdan, France) in severe MGD-related dry eye patients. MATERIALS AND METHODS This non-comparative study included 20 patients with MGD-related dry eye with a Break-Up Time (BUT)<10seconds, dry eye symptoms >30mm on a Visual Analog Scale (VAS), and failure of lid hygiene and artificial tears. Treatment consisted of 3 sessions of IPL on D0, D15, and D45 (5 flashes of 13J/cm2 per eye). The following parameters were assessed at each visit and at D75 : symptoms graded with a VAS and the Standard Patient Assessment of Eye Dryness questionnaire (SPEED), BUT, corneal fluorescein staining, Meibomian gland expression score, meibography, tear film lipid layer thickness by interferometry and the ocular scattering index by double-pass aberrometry (OQAS). Statistical analysis was performed on the eye most affected at baseline. RESULTS We included 40 eyes of 20 patients, 15 female and 5 male, mean age 47±15 years (24 to 74 years). The symptoms rated by VAS were severe, averaging 69±25mm. After treatment, there was a statistically significant decrease in symptoms, with a 14mm VAS decrease (55±29mm at D75 versus 69mm at D0, P=0.048) and SPEED score of 3.4 (19.0±6mm versus 22.4±4.6, P=0.03). The number of expressible Meibomian gland ducts increased significantly (from 5.9 to 8.1, P=0.04), lid redness decreased (from 1.4 to 0.6, P=NS) and BUT improved (from 4.2 to 5.9, P=NS). Other parameters remained unchanged. Three patients (15%) complained of transient ocular burning after each treatment. CONCLUSION IPL appears to be effective in improving signs and symptoms in patients with severe MGD-related dry eye, with a good safety profile. Its exact mechanism of action remains to be elucidated.
Collapse
Affiliation(s)
- S Egri
- Service d'Ophtalmologie, Fondation Adolphe-de-Rothschild, Paris, France
| | - I Van Hollebecke
- Service d'Ophtalmologie, Fondation Adolphe-de-Rothschild, Paris, France
| | - D Guindolet
- Service d'Ophtalmologie, Fondation Adolphe-de-Rothschild, Paris, France
| | - C Manenti
- Service d'Ophtalmologie, Fondation Adolphe-de-Rothschild, Paris, France
| | - H Rougier
- Service d'Ophtalmologie, Fondation Adolphe-de-Rothschild, Paris, France
| | - É Gabison
- Service d'Ophtalmologie, Fondation Adolphe-de-Rothschild, Paris, France
| | - I Cochereau
- Service d'Ophtalmologie, Fondation Adolphe-de-Rothschild, Paris, France
| | - S Doan
- Service d'Ophtalmologie, Fondation Adolphe-de-Rothschild, Paris, France.
| |
Collapse
|
6
|
Bush A, Lintowska A, Mazur A, Hadjipanayis A, Grossman Z, Del Torso S, Michaud PA, Doan S, Romankevych I, Slaats M, Utkus A, Dembiński Ł, Slobodanac M, Valiulis A. E-Cigarettes as a Growing Threat for Children and Adolescents: Position Statement From the European Academy of Paediatrics. Front Pediatr 2021; 9:698613. [PMID: 34737999 PMCID: PMC8562300 DOI: 10.3389/fped.2021.698613] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 04/21/2021] [Accepted: 09/08/2021] [Indexed: 12/02/2022] Open
Abstract
As the tobacco epidemic has waned, it has been followed by the advent of electronic nicotine delivery devices (ENDS) primarily manufactured by the tobacco industry to try to recruit replacements for deceased tobacco addicts. This document sets out the ten recommendations of the European Academy of Paediatrics (EAP) with regard to e-cigarettes and children and young people (CYP). The EAP notes that nicotine is itself a drug of addiction, with toxicity to the foetus, child and adult, and were ENDS only to contain nicotine, their use to create a new generation of addicts would be rigorously opposed. However, e-cigarettes include numerous unregulated chemicals, including known carcinogens, whose acute and long term toxicities are unknown. The EAP asserts that there is incontrovertible evidence that the acute toxicity of e-cigarettes is greater than that of "traditional" tobacco smoking, and a variety of acute pulmonary toxicities, including acute lung injuries, have been recorded due to e-cigarettes usage. The chronic toxicity of e-cigarettes is unknown, but given the greater acute toxicity compared to tobacco, the EAP cannot assume that e-cigarettes are safer in the long term. The high uptake of e-cigarettes by CYP, including under-age children, is partly fuelled by deceitful marketing and internet exposure, which is also unregulated. Although proposed as aids to smoking cessation, there is no evidence that e-cigarettes add anything to standard smoking cessation strategies. In summary, the EAP regards these devices and liquids as very dangerous, and ineluctably opposed to their use, and their direct or indirect marketing.
Collapse
Affiliation(s)
- Andrew Bush
- Imperial College Centre for Paediatrics and Child Health, National Heart and Lung Institute, Royal Brompton Harefield NHS Foundation Trust, London, United Kingdom
| | - Agnieszka Lintowska
- Department of Health Promotion, Faculty of Health Science, Wroclaw Medical University, Wroclaw, Poland
| | - Artur Mazur
- Institute of Medical Sciences, Medical College, University of Rzeszów, Rzeszow, Poland.,European Academy of Paediatric (EAP/UEMS-SP), Brussels, Belgium
| | - Adamos Hadjipanayis
- European Academy of Paediatric (EAP/UEMS-SP), Brussels, Belgium.,Medical School, European University of Cyprus, Nicosia, Cyprus
| | - Zacchi Grossman
- European Academy of Paediatric (EAP/UEMS-SP), Brussels, Belgium.,Adelson School of Medicine, Ariel University, Ariel, Israel.,Maccabi Health Services, Tel Aviv, Israel
| | - Stefano Del Torso
- European Academy of Paediatric (EAP/UEMS-SP), Brussels, Belgium.,Pediatra di Famiglia ULSS 16, Padua, Italy
| | - Pierre-André Michaud
- Faculté de Biologie et de Médecine, Université de Lausanne, Lausanne, Switzerland
| | - Svitlana Doan
- Department of Public Health and Microbiology, Kyiv Medical University, Kyiv, Ukraine
| | - Ivanna Romankevych
- Shupyk National Medical Academy of Postgraduate Education, Kyiv, Ukraine
| | - Monique Slaats
- European Academy of Paediatric (EAP/UEMS-SP), Brussels, Belgium.,Pediatric Pulmonology, Sophia Children's Hospital, Rotterdam, Netherlands
| | - Algirdas Utkus
- Department of Human and Medical Genetics, Institute of Biomedical Sciences, Vilnius University Medical Faculty, Vilnius, Lithuania
| | - Łukasz Dembiński
- European Academy of Paediatric (EAP/UEMS-SP), Brussels, Belgium.,Department of Pediatric Gastroenterology and Nutrition, Medical University of Warsaw, Warsaw, Poland
| | | | - Arunas Valiulis
- European Academy of Paediatric (EAP/UEMS-SP), Brussels, Belgium.,Clinic of Children's Diseases, Institute of Clinical Medicine, and Department of Public Health, Institute of Health Sciences, Vilnius University Medical Faculty, Vilnius, Lithuania
| |
Collapse
|
7
|
Combemale L, Alexandre M, Sitbon I, Pascal F, Soued I, Doan S, Caux F, Prost-Squarcioni C, Le Roux-Villet C. Lichen plan pemphigoïde avec atteinte muqueuse : étude de 12 cas. Ann Dermatol Venereol 2020. [DOI: 10.1016/j.annder.2020.09.008] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
8
|
Ben Hadj Salah W, Baudouin C, Doan S, Angoulvant A, Gottlieb J, Bénichou J, Da Cunha E, Eid L, Labetoulle M, Rousseau A. [Demodex and ocular surface disease]. J Fr Ophtalmol 2020; 43:1069-1077. [PMID: 33127178 DOI: 10.1016/j.jfo.2020.08.002] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/28/2020] [Revised: 08/08/2020] [Accepted: 08/24/2020] [Indexed: 12/12/2022]
Abstract
Demodex is a saprophytic mite of the ocular adnexa, which can in certain circumstances proliferate on the skin of the face and on the eyelid margins. It is involved in facial rosacea (especially in the papulopustular form) and in the development or aggravation of anterior and/or posterior blepharitis or even keratoconjunctivitis, often in association with cutaneous lesions ; the pathophysiology is often multifactorial. Symptoms are non-specific, but the presence of cylindrical sleeves on the eyelashes is very suggestive of infestation, and certain techniques of biomicroscopic examination or imaging, such as confocal microscopy in vivo, allow direct visualization of the parasite. Parasitological examination of the eyelashes can confirm the diagnosis and can be improved by good sampling technique. Eyelid hygiene and oil-based ointments are the cornerstone of treatment. New specific treatments, in particular topical treatments based on tea tree oil, ivermectin, as well as pulsed light therapy and micro-exfoliation of the eyelid margin, can help to reduce the parasitic load and improve symptoms.
Collapse
Affiliation(s)
- W Ben Hadj Salah
- Service d'ophtalmologie, hôpital Bicêtre, CHU de Bicêtre, Assistance Publique-Hôpitaux de Paris, université Paris-Saclay, réseau OPHTARA : maladies rares en ophtalmologie, Paris, France
| | - C Baudouin
- Services d'ophtalmologie, CHNO des XV-XX, et hôpital Ambroise-Paré, Assistance Publique-Hôpitaux de Paris, université Versailles-St-Quentin-en-Yvelines, IHU de Sight Restore Saclay, Paris, France; Institut de la vision, Sorbonne université, Inserm, CNRS, Sorbonne, France
| | - S Doan
- Service d'ophtalmologie, CHU de Bichat, Assistance Publique-Hôpitaux de Paris et Fondation ophtalmologique Rothschild, réseau OPHTARA : maladies rares en ophtalmologie, Paris, France
| | - A Angoulvant
- Service de parasitologie, hôpital Bicêtre, CHU de Bicêtre, Assistance Publique-Hôpitaux de Paris, université Paris-Saclay, Paris, France
| | - J Gottlieb
- Service d'immunologie clinique & consultation de dermatologie, hôpital Bicêtre, CHU de Bicêtre, Assistance Publique-Hôpitaux de Paris, université Paris-Saclay, Paris, France
| | - J Bénichou
- Service d'ophtalmologie, hôpital Bicêtre, CHU de Bicêtre, Assistance Publique-Hôpitaux de Paris, université Paris-Saclay, réseau OPHTARA : maladies rares en ophtalmologie, Paris, France
| | - E Da Cunha
- Service d'ophtalmologie, hôpital Bicêtre, CHU de Bicêtre, Assistance Publique-Hôpitaux de Paris, université Paris-Saclay, réseau OPHTARA : maladies rares en ophtalmologie, Paris, France
| | - L Eid
- Service d'ophtalmologie, hôpital Bicêtre, CHU de Bicêtre, Assistance Publique-Hôpitaux de Paris, université Paris-Saclay, réseau OPHTARA : maladies rares en ophtalmologie, Paris, France
| | - M Labetoulle
- Service d'ophtalmologie, hôpital Bicêtre, CHU de Bicêtre, Assistance Publique-Hôpitaux de Paris, université Paris-Saclay, réseau OPHTARA : maladies rares en ophtalmologie, Paris, France; Département immunologie des maladies virales, auto-immunes, bactériennes et hématologiques (IMVA-HB). UMR 1184, CEA, Fontenay-Aux-Roses, France
| | - A Rousseau
- Service d'ophtalmologie, hôpital Bicêtre, CHU de Bicêtre, Assistance Publique-Hôpitaux de Paris, université Paris-Saclay, réseau OPHTARA : maladies rares en ophtalmologie, Paris, France; Département immunologie des maladies virales, auto-immunes, bactériennes et hématologiques (IMVA-HB). UMR 1184, CEA, Fontenay-Aux-Roses, France.
| |
Collapse
|
9
|
Affiliation(s)
- M Labetoulle
- Service d'ophtalmologie, hôpital de Bicêtre, 78, avenue du Général-Leclerc, 94275 Le Kremlin-Bicêtre, France; IDMIT Infrastructure, CEA, Université Paris Sacaly, Inserm U1184, 18, route du Panorama, 92265 Fontenay-aux-Roses cedex, France.
| | - S Doan
- Service d'ophtalmologie, hôpital de Bicêtre, 78, avenue du Général-Leclerc, 94275 Le Kremlin-Bicêtre, France; Hôpital Fondation Adolphe de Rothschild, 29, rue Manin, 75019 Paris, France
| | - A Rousseau
- Service d'ophtalmologie, hôpital de Bicêtre, 78, avenue du Général-Leclerc, 94275 Le Kremlin-Bicêtre, France; IDMIT Infrastructure, CEA, Université Paris Sacaly, Inserm U1184, 18, route du Panorama, 92265 Fontenay-aux-Roses cedex, France
| |
Collapse
|
10
|
Arndt C, Audrun F, Bodaghi B, Caujolle JP, Cassoux N, Defoort S, Delyfer MN, Denis P, Doan S, Fenolland JR, Giraud JM, Kodjikian L, Labetoulle M, Lasudry J, Leveziel N, Rousseau A, Saadoun D, Speeg-Schatz C, Touhami S, Touitou V, Vignal C, Zech C. [Categorization of the degree of urgency according to ophthalmology procedures or situations]. J Fr Ophtalmol 2020; 43:525-528. [PMID: 32409227 DOI: 10.1016/j.jfo.2020.04.008] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/24/2020] [Accepted: 04/27/2020] [Indexed: 11/19/2022]
Affiliation(s)
- C Arndt
- Société française d'ophtalmologie, 17, VLA d'Alésia, 75014 Paris, France
| | - F Audrun
- Société française d'ophtalmologie, 17, VLA d'Alésia, 75014 Paris, France
| | - B Bodaghi
- Société française d'ophtalmologie, 17, VLA d'Alésia, 75014 Paris, France
| | - J-P Caujolle
- Société française d'ophtalmologie, 17, VLA d'Alésia, 75014 Paris, France
| | - N Cassoux
- Société française d'ophtalmologie, 17, VLA d'Alésia, 75014 Paris, France
| | - S Defoort
- Société française d'ophtalmologie, 17, VLA d'Alésia, 75014 Paris, France
| | - M-N Delyfer
- Société française d'ophtalmologie, 17, VLA d'Alésia, 75014 Paris, France
| | - P Denis
- Société française d'ophtalmologie, 17, VLA d'Alésia, 75014 Paris, France
| | - S Doan
- Société française d'ophtalmologie, 17, VLA d'Alésia, 75014 Paris, France
| | - J-R Fenolland
- Société française d'ophtalmologie, 17, VLA d'Alésia, 75014 Paris, France
| | - J-M Giraud
- Société française d'ophtalmologie, 17, VLA d'Alésia, 75014 Paris, France
| | - L Kodjikian
- Société française d'ophtalmologie, 17, VLA d'Alésia, 75014 Paris, France.
| | - M Labetoulle
- Société française d'ophtalmologie, 17, VLA d'Alésia, 75014 Paris, France
| | - J Lasudry
- Société française d'ophtalmologie, 17, VLA d'Alésia, 75014 Paris, France
| | - N Leveziel
- Société française d'ophtalmologie, 17, VLA d'Alésia, 75014 Paris, France
| | - A Rousseau
- Société française d'ophtalmologie, 17, VLA d'Alésia, 75014 Paris, France
| | - D Saadoun
- Société française d'ophtalmologie, 17, VLA d'Alésia, 75014 Paris, France
| | - C Speeg-Schatz
- Société française d'ophtalmologie, 17, VLA d'Alésia, 75014 Paris, France
| | - S Touhami
- Société française d'ophtalmologie, 17, VLA d'Alésia, 75014 Paris, France
| | - V Touitou
- Société française d'ophtalmologie, 17, VLA d'Alésia, 75014 Paris, France
| | - C Vignal
- Société française d'ophtalmologie, 17, VLA d'Alésia, 75014 Paris, France
| | - C Zech
- Société française d'ophtalmologie, 17, VLA d'Alésia, 75014 Paris, France
| |
Collapse
|
11
|
Malysh N, Chemych M, Doan S, Rodyna R. Epidemiological characteristics of acute intestinal infection outbreaks in Ukraine Under the current conditions. Bangladesh J Med Sci 2018. [DOI: 10.3329/bjms.v18i1.39552] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022] Open
Abstract
Objective: determination of epidemiological peculiarities of acute intestinal infections outbreak incidence in Ukraine for the period 2014-2017.
Materials and methods: Applying descriptive and analytical techniques of an epidemiological research method and statistical methods, using materials of the official statutory records of the Ministry of Health of Ukraine, the nature of acute intestinal infection outbreaks by etiology, transmission routes and affected cohort groups was investigated.
Result and discussion: At the current stage AII outbreaks are registered every year and throughout Ukraine. Herewith, their specific gravity in total diarrheal infection incidence, excluding shigellosis and salmonellosis, is insignificant. Outbreak incidence levels in the industrial and tourist centres of Ukraine exceed similar rates in other regions by several times. Salmonelloses dominate in the nosological structure of outbreak incidence. The majority of outbreaks is transmitted by food. Most of diarrheal infection outbreaks are connected with catering facilities and children’s pre-school institutions, as well as with visiting festive occasions arranged at home. A rise in outbreak incidence is observed from May till September. Rotaviral enteritis outbreaks are more frequently registered in January through March.
Conclusion: The detected peculiarities of acute intestinal infection outbreak incidence shall be considered when developing regional programs of epidemiological surveillance over diarrheal infections.
Bangladesh Journal of Medical Science Vol.18(1) 2019 p.73-77
Collapse
|
12
|
Maillard A, Alby C, Aberdam D, Gabison E, Doan S, Bodermer C, Hadj-Rabia S. Dysplasies ectodermiques P63 : caractérisation dermatologique et corrélation génotype–phénotype. Ann Dermatol Venereol 2018. [DOI: 10.1016/j.annder.2018.09.406] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
|
13
|
Roriz M, Alexandra J, Bertinchamp R, Chauveheid M, Cohen Aubart F, Doan S, Dossier A, Goulenok T, Klein I, Rouzaud D, Sacré K, Papo T. Syndrome de SUSAC : séquelles et absence de facteurs cliniques prédictifs. Rev Med Interne 2018. [DOI: 10.1016/j.revmed.2018.10.370] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
|
14
|
Leonardi A, Doan S, Fauquert JL, Bozkurt B, Allegri P, Marmouz F, Rondon C, Jedrzejczak M, Hellings P, Delgado L, Calder V. Diagnostic tools in ocular allergy. Allergy 2017; 72:1485-1498. [PMID: 28387947 DOI: 10.1111/all.13178] [Citation(s) in RCA: 35] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 04/04/2017] [Indexed: 12/21/2022]
Abstract
Ocular allergy (OA) includes a group of common and less frequent hypersensitivity disorders frequently misdiagnosed and not properly managed. The diagnosis of OA is usually based on clinical history and signs and symptoms, with the support of in vivo and in vitro tests when identification of the specific allergen is required. To date, no specific test is available for the diagnosis of the whole spectrum of the different forms of OA. The lack of recommendations on diagnosis of OA is considered a medical need not only for allergists but also for ophthalmologists. This position paper aims to provide a comprehensive overview of the currently available tools for diagnosing OA to promote a common nomenclature and procedures to be used by different specialists. Questionnaires, sign and symptom grading scales, tests, and potential biomarkers for OA are reviewed. We also identified several unmet needs in the diagnostic tools to generate interest, increase understanding, and inspire further investigations. Tools, recommendations, and algorithms for the diagnosis of OA are proposed for use by both allergists and ophthalmologists. Several unmet needs in the diagnostic tools should be further improved by specific clinical research in OA.
Collapse
Affiliation(s)
- A. Leonardi
- Department of Neuroscience; Ophthalmology Unit; University of Padua; Padua Italy
| | - S. Doan
- Service d'Ophtalmologie; Hôpital Bichat and Fondation A. de Rothschild; Paris France
| | - J. L. Fauquert
- Unité d'Allergologie de l'Enfant CHU Estaing; CHU Estaing; Clermont-Ferrand Cedex1 France
| | - B. Bozkurt
- Faculty of Medicine; Department of Ophthalmology; Selcuk University; Konya Turkey
| | - P. Allegri
- Rapallo Hospital Ophthalmology Department; Allergic Conjunctivitis Unit; Ocular Inflammatory Diseases Referral Center; Genova Italy
| | - F. Marmouz
- Pole sanitaire du Vexin; Pontoise France
| | - C. Rondon
- Allergy Unit; Regional University Hospital of Malaga; IBIMA, UMA; Malaga Spain
| | - M. Jedrzejczak
- Department of Immunology, Rheumatology and Allergy; Medical University of Lodz; Lodz Poland
| | | | - L. Delgado
- Laboratory of Immunology; Faculty of Medicine; Basic and Clinical Immunology Unit, and Center for Research in Health Technologies and Information Systems (CINTESIS); University of Porto; Porto Portugal
| | - V. Calder
- Department of Ocular Biology & Therapeutics; UCL Institute of Ophthalmology; London UK
| |
Collapse
|
15
|
Vitte J, Baye A, Batellier L, Doan S, Bury T. Molecular diagnostics of ocular allergy. Acta Ophthalmol 2017. [DOI: 10.1111/j.1755-3768.2017.03353] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Affiliation(s)
- J. Vitte
- IHU Méditerranée Infection, UF Immunologie; Marseille France
| | - A. Baye
- IHU Méditerranée Infection, UF Immunologie; Marseille France
| | - L. Batellier
- IHU Méditerranée Infection, UF Immunologie; Marseille France
| | - S. Doan
- IHU Méditerranée Infection, UF Immunologie; Marseille France
| | - T. Bury
- IHU Méditerranée Infection, UF Immunologie; Marseille France
| |
Collapse
|
16
|
Dubaut J, Doan S, Wild R, Craig L, Williams W. Fenbendazole treatment is associated with increased cycle fecundity rate in subfertile baboons. Fertil Steril 2017. [DOI: 10.1016/j.fertnstert.2017.02.015] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
|
17
|
Fauquert JL, Jedrzejczak-Czechowicz M, Rondon C, Calder V, Silva D, Kvenshagen BK, Callebaut I, Allegri P, Santos N, Doan S, Perez Formigo D, Chiambaretta F, Delgado L, Leonardi A. Conjunctival allergen provocation test : guidelines for daily practice. Allergy 2017; 72:43-54. [PMID: 27430124 DOI: 10.1111/all.12986] [Citation(s) in RCA: 57] [Impact Index Per Article: 8.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 07/14/2016] [Indexed: 01/15/2023]
Abstract
Conjunctival allergen provocation test (CAPT) reproduces the events occurring by instilling an allergen on the ocular surface. This paper is the compilation of a task force focussed on practical aspects of this technique based on the analysis of 131 papers. Main mechanisms involved are reviewed. Indications are diagnosing the allergen(s)-triggering symptoms in IgE-mediated ocular allergy in seasonal, acute or perennial forms of allergic conjunctivitis, especially when the relevance of the allergen is not obvious or in polysensitized patients. Contraindications are limited to ongoing systemic severe pathology, asthma and eye diseases. CAPT should be delayed if receiving systemic steroids or antihistamines. Local treatment should be interrupted according to the half-life of each drug. Prerequisites are as follows: obtaining informed consent; evidencing of an allergen by skin prick tests and/or serum-specific IgE dosages; being able to deal with an unlikely event such as acute asthma exacerbation, urticaria or anaphylaxis, or an exacerbation of allergic conjunctivitis. Allergen extracts should be diluted locally prior to administration. Positive criteria are based on itching or quoted according to a composite score. An alternative scoring is based on itching. CAPT remains underused in daily practice, although it is a safe and simple procedure which can provide valuable clinical information.
Collapse
Affiliation(s)
- J.-L. Fauquert
- Unité d'Allergologie de l'enfant; CHU Estaing; Clermont-Ferrand Cedex 1 France
| | | | - C. Rondon
- Allergy Unit; Regional University Hospital of Malaga; IBIMA; UMA; Malaga Spain
| | - V. Calder
- Department of Ocular Biology & Therapeutics (ORBIT); UCL Institute of Ophthalmology; London UK
| | - D. Silva
- Serviço de Imunoalergologia; Centro Hospitalar São João; E.P.E.; Porto Portugal
| | - B. K. Kvenshagen
- Pediatric Department; Oestfold Hospital Trust; Fredrikstad Norway
| | - I. Callebaut
- Clinical Immunology; Department of Microbiology and Immunology; Catholic University of Leuven; Leuven Belgium
| | - P. Allegri
- Allergic Conjunctivitis Unit; Ocular Inflammatory Diseases Referral Center; Rapallo Hospital Ophthalmological Dep.; Genova Italy
| | - N. Santos
- Serviço de Imunoalergologia; Centro Hospitalar São João; E.P.E.; Porto Portugal
| | - S. Doan
- Service d'Ophtalmologie; Hôpital Bichat and Fondation A. de Rothschild; Paris France
| | - D. Perez Formigo
- Servicio de Oftalmologia; Hospital Universitario de Torrejon; Madrid Spain
| | - F. Chiambaretta
- Service d'Ophtalmologie; CHU Montpied; Clermont-Ferrand Cedex 1 France
| | - L. Delgado
- Department of Immunology; Faculty of Medicine; University of Porto; Porto Portugal
| | - A. Leonardi
- Ophthalmology Unit; Department of Neuroscience; University of Padua; Padua Italy
| | | |
Collapse
|
18
|
Doan S, Zagórski Z, Palmares J, Yağmur M, Kaercher T, Van Dooren B, Jonckheere P, Jensen P, Benitez del Castillo J. Evaluation of the eyelid disorders in the daily ophthalmic practice in 9 European Countries: The MEIBUM* survey. Acta Ophthalmol 2016. [DOI: 10.1111/j.1755-3768.2016.0577] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
19
|
Doan S, Delcampe A. Moderate to severe dry eye - a promising indication for scleral lenses. Acta Ophthalmol 2016. [DOI: 10.1111/j.1755-3768.2016.0104] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
20
|
Seta V, Alexandre M, Zumelzu C, Oro S, Bernardeschi C, Schneider P, Le Roux-Villet C, Pascal F, Weber P, Doan S, Soued I, Raynaud J, Benamouzig R, Vibert J, Tancrède E, Dupin N, Laroche L, Caux F, Tubach F, Prost-Squarcioni C, Gault N. Morbidité et facteurs pronostiques dans la pemphigoïde cicatricielle : étude de cohorte rétrospective. Rev Epidemiol Sante Publique 2016. [DOI: 10.1016/j.respe.2016.03.041] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022] Open
|
21
|
Seta V, Gault N, Alexandre M, Zumelzu C, Oro S, Bernardeschi C, Schneider P, Le Roux Villet C, Pascal F, Weber P, Doan S, Soued I, Raynaud JJ, Lièvre N, Heller M, Tancrède E, Benamouzig R, Vibert JF, Dupin N, Wolkenstein P, Laroche L, Caux F, Tubach F, Prost-Squarcioni C. Morbidité et facteurs pronostiques dans la pemphigoïde cicatricielle : étude rétrospective sur 121 patients. Ann Dermatol Venereol 2015. [DOI: 10.1016/j.annder.2015.10.054] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
|
22
|
Alexandre M, Seta V, Zumelzu C, Vibert JF, Le Roux Villet C, Doan S, Soued I, Pascal F, Lièvre N, Heller M, Caux F, Laroche L, Prost C. Efficacité du rituximab dans les pemphigoïdes des muqueuses. Ann Dermatol Venereol 2015. [DOI: 10.1016/j.annder.2015.10.055] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
23
|
Rossi P, Delcampe A, Gueudry J, Duncombe A, Gabison E, Doan S, Muraine M. Traitement des sécheresses oculaires sévères secondaires à la maladie du greffon contre l’hôte chronique par lentilles sclérales perméables à l’oxygène. J Fr Ophtalmol 2015; 38:793-9. [DOI: 10.1016/j.jfo.2015.04.012] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/18/2015] [Revised: 03/27/2015] [Accepted: 04/10/2015] [Indexed: 10/22/2022]
|
24
|
Stephan S, Rouger H, Doan S, Lamirel C, Cochereau I, Gabison E. Neurotrophic keratitis (NK) in carotid cavernous fistulae (CCF). Acta Ophthalmol 2015. [DOI: 10.1111/j.1755-3768.2015.0618] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Affiliation(s)
- S. Stephan
- Ophtalmology; Fondation A. de Rothschild; Paris France
| | - H. Rouger
- Ophtalmology; Fondation A. de Rothschild; Paris France
| | - S. Doan
- Ophtalmology; Fondation A. de Rothschild; Paris France
| | - C. Lamirel
- Ophtalmology; Fondation A. de Rothschild; Paris France
| | - I. Cochereau
- Ophtalmology; Fondation A. de Rothschild; Paris France
| | - E. Gabison
- Ophtalmology; Fondation A. de Rothschild; Paris France
| |
Collapse
|
25
|
Doan S, Amat F, Gabison E, Just J, Cochereau I. Experience with the monoclonal anti IgE antibody Omalizumab in severe refractory vernal keratoconjunctivitis in children. Acta Ophthalmol 2015. [DOI: 10.1111/j.1755-3768.2015.0525] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
Affiliation(s)
- S. Doan
- Ophthalmology; Hopital Bichat and Fondation A de Rothschild; Paris France
| | - F. Amat
- Allergology; Hopital Trousseau; Paris France
| | - E. Gabison
- Ophthalmology; Hopital Bichat and Fondation A de Rothschild; Paris France
| | - J. Just
- Allergology; Hopital Trousseau; Paris France
| | - I. Cochereau
- Ophthalmology; Hopital Bichat and Fondation A de Rothschild; Paris France
| |
Collapse
|
26
|
Diaz Valle D, Doan S, Yagmur M, Benitez del Castillo J. Eyelid disorders evaluation in the Ophthalmic current practice in Belgium, Denmark, France, Netherland, Portugal and Turkey: The Meibum Study. Acta Ophthalmol 2015. [DOI: 10.1111/j.1755-3768.2015.0603] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022]
Affiliation(s)
- D. Diaz Valle
- Hospital Clinico San Carlos; Servicio de Oftalmologia; Madrid Spain
| | - S. Doan
- Départment ophthalmologie; Hôpital Bichat- Fondation A de Rothschild- Paris- France; Paris France
| | - M. Yagmur
- The Medicine Faculty Balcali Hospita; Cukurova University; Adana Turkey
| | | |
Collapse
|
27
|
Doan S, Baudouin C, Khairallah M. Randomised, controlled study of the efficacy and safety of a new eye-drop formulation for moderate to severe dry eye syndrome. Acta Ophthalmol 2015. [DOI: 10.1111/j.1755-3768.2015.1553] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
Affiliation(s)
- S. Doan
- Hopital Bichat; Ophtalmologie; Paris France
| | - C. Baudouin
- CHNO des XV-XX; Service Ophtalmologie III; Paris France
| | - M. Khairallah
- Hôpital Fattouma Bourguiba; Service d'ophthalmologie; Monastir Tunisia
| |
Collapse
|
28
|
Doan S, Baudouin C, Khairallah M. Randomised, controlled study of the efficacy and safety of a new eye-drop formulation for moderate to severe dry eye syndrome. Acta Ophthalmol 2015. [DOI: 10.1111/j.1755-3768.2015.0553] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
Affiliation(s)
- S. Doan
- Ophtalmologie; Hopital Bichat; Paris France
| | - C. Baudouin
- CHNO des XV-XX; Service Ophtalmologie III; Paris France
| | - M. Khairallah
- Hôpital Fattouma Bourguiba; Service d'ophthalmologie; Monastir Tunisia
| |
Collapse
|
29
|
Rousseau A, Labbé A, Baudouin C, Cochereau I, Gabison E, Doan S. In vivo confocal microscopy and spectral domain anterior segment OCT in Lisch epithelial corneal dystrophy. J Fr Ophtalmol 2015; 38:e151-3. [PMID: 26144589 DOI: 10.1016/j.jfo.2014.07.017] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/23/2014] [Revised: 07/06/2014] [Accepted: 07/21/2014] [Indexed: 11/29/2022]
Affiliation(s)
- A Rousseau
- Service d'ophtalmologie, hôpital Bichat, Assistance publique-Hôpitaux de Paris, université Paris VII, 46, rue Henri-Huchard, 75018 Paris, France.
| | - A Labbé
- Services d'ophtalmologie, centre hospitalier national ophtalmologique des Quinze-Vingts, 28, rue de Charenton, 75012 Paris, France
| | - C Baudouin
- Services d'ophtalmologie, centre hospitalier national ophtalmologique des Quinze-Vingts, 28, rue de Charenton, 75012 Paris, France
| | - I Cochereau
- Service d'ophtalmologie, hôpital Bichat, Assistance publique-Hôpitaux de Paris, université Paris VII, 46, rue Henri-Huchard, 75018 Paris, France
| | - E Gabison
- Service d'ophtalmologie, hôpital Bichat, Assistance publique-Hôpitaux de Paris, université Paris VII, 46, rue Henri-Huchard, 75018 Paris, France
| | - S Doan
- Service d'ophtalmologie, hôpital Bichat, Assistance publique-Hôpitaux de Paris, université Paris VII, 46, rue Henri-Huchard, 75018 Paris, France
| |
Collapse
|
30
|
Guindolet D, Amaouche N, Doan S, Cochereau I, Gabison É. Mucous Fishing Syndrome : à propos d’un cas et revue de la littérature. J Fr Ophtalmol 2015; 38:e47-8. [DOI: 10.1016/j.jfo.2014.04.032] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/26/2014] [Revised: 04/21/2014] [Accepted: 04/23/2014] [Indexed: 11/28/2022]
|
31
|
Poirier E, Soued I, Alexandre M, Boussoura S, Lamberto C, Uzunhan Y, Gharbi N, Pascal F, Doan S, Brillet PY, Caux F, Laroche L, Prost-Squarcioni C. Pemphigoïde des muqueuses avec sténoses laryngées ou trachéales : série de 11 cas. Ann Dermatol Venereol 2014. [DOI: 10.1016/j.annder.2014.09.091] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
|
32
|
Alexandre M, Le Roux C, Doan S, Soued I, Pascal F, Heller M, Lièvre N, Caux F, Laroche L, Prost C. Morbidité à un an de la pemphigoïde cicatricielle : étude rétrospective sur 60 cas. Ann Dermatol Venereol 2013. [DOI: 10.1016/j.annder.2013.09.056] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022]
|
33
|
Munyangango E, Le Roux-Villet C, Doan S, Pascal F, Soued I, Alexandre M, Heller M, Lièvre N, Aucouturier F, Caux F, Laroche L, Prost-Squarcioni C. Oral cyclophosphamide without corticosteroids to treat mucous membrane pemphigoid. Br J Dermatol 2013; 168:381-90. [DOI: 10.1111/bjd.12041] [Citation(s) in RCA: 39] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/22/2022]
|
34
|
Leonardi A, Bogacka E, Fauquert JL, Kowalski ML, Groblewska A, Jedrzejczak-Czechowicz M, Doan S, Marmouz F, Demoly P, Delgado L. Ocular allergy: recognizing and diagnosing hypersensitivity disorders of the ocular surface. Allergy 2012; 67:1327-37. [PMID: 22947083 DOI: 10.1111/all.12009] [Citation(s) in RCA: 131] [Impact Index Per Article: 10.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 07/20/2012] [Indexed: 12/28/2022]
Abstract
Ocular allergy includes several clinically different conditions that can be considered as hypersensitivity disorders of the ocular surface. The classification of these conditions is complex, and their epidemiology has not been adequately studied because of the lack of unequivocal nomenclature. Ocular allergy symptoms are often, but not always, associated with other allergic manifestations, mostly rhinitis. However, specific ocular allergic diseases need to be recognized and managed by a team that includes both an ophthalmologist and an allergist. The diagnosis of ocular allergy is usually based on clinical history and signs and symptoms, with the support of in vivo and in vitro tests when the identification of the specific allergic sensitization is required for patient management. The aims of this Task Force Report are (i) to unify the nomenclature and classification of ocular allergy, by combining the ophthalmology and allergy Allergic Rhinitis and its Impact on Asthma criteria; (ii) to describe current methods of diagnosis; (iii) to summarize the therapeutic options for the management of ocular allergic inflammation.
Collapse
Affiliation(s)
- A. Leonardi
- Department of Neuroscience; Ophthalmology Unit; University of Padua; Padua; Italy
| | - E. Bogacka
- Department of Internal Medicine, Allergy and Geriatrics; Medical Academy of Wrocław; Wrocław; Poland
| | - J. L. Fauquert
- Unité d'Allergologie de l'enfant; CHU Estaing; Clermont-Ferrand; France
| | - M. L. Kowalski
- Department of Immunology, Rheumatology and Allergy; Medical University of Lodz; Łódź; Poland
| | - A. Groblewska
- Department of Ophthalmology; Polish Mother's Memorial Hospital; Łódź; Poland
| | | | - S. Doan
- Hopital Bichat and Fondation A. de Rothschild; Paris; France
| | - F. Marmouz
- Pole sanitaire du Vexin; Pontoise; France
| | - P. Demoly
- Inserm U454 - IFR3; hôpital Arnaud-de-Villeneuve; Montpellier; France
| | - L. Delgado
- Faculty of Medicine; Department of Immunology; University of Porto; Porto; Portugal
| |
Collapse
|
35
|
Nicolau R, Doan S, Cochereau I. [Sunset (Morgagnian) cataract]. J Fr Ophtalmol 2012; 35:391. [PMID: 22464866 DOI: 10.1016/j.jfo.2011.11.006] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/03/2011] [Accepted: 11/22/2011] [Indexed: 10/28/2022]
Affiliation(s)
- R Nicolau
- Service d'ophtalmologie, fondation ophtalmologique Adolphe-de-Rothschild, 29, rue Manin, 75019 Paris, France.
| | | | | |
Collapse
|
36
|
Papo T, Klein I, Sacré K, Doan S, Bodaghi B, Aubart-Cohen F. Syndrome de Susac. Rev Med Interne 2012; 33:94-8. [DOI: 10.1016/j.revmed.2011.11.002] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/30/2011] [Accepted: 11/03/2011] [Indexed: 11/16/2022]
|
37
|
Lidove O, Chauveheid MP, Caillaud C, Froissart R, Benoist L, Alamowitch S, Doan S, Szalat R, Baumann N, Alexandra JF, Lavallée P, Klein I, Vuillemet F, Sedel F, Sacré K, Samson Y, Roullet E, Papo T. Aseptic meningitis and ischaemic stroke in Fabry disease. Int J Clin Pract 2009; 63:1663-7. [PMID: 19832823 DOI: 10.1111/j.1742-1241.2009.02115.x] [Citation(s) in RCA: 20] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/30/2022] Open
Abstract
BACKGROUND Fabry disease (OMIM 301 500) is an X-linked lysosomal storage disease. Neurological symptoms in Fabry disease mainly include stroke, acroparesthesia, cranial nerve palsies and autonomic dysfunction. We report on aseptic meningitis in Fabry patients. METHODS Clinical analysis, brain magnetic resonance imaging, cerebrospinal fluid analysis, treatment and outcome data were analysed in three cases of meningitis associated with Fabry disease. FINDINGS Mean age at meningitis onset was 26.6 (24-28) years. Headache was present in all cases and fever in two cases. Meningitis was always diagnosed before Fabry disease. A familial history of Fabry disease was present in two cases. Non-neurological symptoms caused by Fabry disease were present in all cases. All patients also suffered stroke and sensorineural hearing loss. Cerebrospinal fluid (CSF) analysis showed pleocytosis (mean, 36; range: 8-76 cells/mm(3)) and a high protein level (mean, 63; range, 47-70 mg/dl). C-reactive protein blood levels and erythrocyte sedimentation rate were raised. Diagnosis was assessed by low alpha-galactosidase A dosage and/or gene mutation analysis in all cases. All patients were treated with enzyme replacement therapy (ERT). In two cases, lumbar puncture was repeatedly performed and there was no normalisation of CSF under ERT alone, at 9 and 24 months of follow-up, respectively. One patient who suffered intracranial hypertension was treated efficiently with steroids, associated with azathioprine. The fact that Fabry disease could be an auto-inflammatory disorder is discussed. INTERPRETATION Fabry disease may cause aseptic meningitis.
Collapse
Affiliation(s)
- O Lidove
- Department of Internal Medicine, Hôpital Bichat Claude-Bernard, 75877 Paris, France.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
38
|
|
39
|
Zribi H, Descamps V, Hoang-Xuan T, Crickx B, Doan S. Dramatic improvement of atopic keratoconjunctivitis after topical treatment with tacrolimus ointment restricted to the eyelids. J Eur Acad Dermatol Venereol 2009; 23:489-90. [PMID: 18721214 DOI: 10.1111/j.1468-3083.2008.02933.x] [Citation(s) in RCA: 22] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
40
|
Gabison E, Chastang P, Doan S, Catanese M, Hoang-Xuan T, Cochereau I. 310 Greffes lamellaires cornéo-sclérales dans la prise en charge des amincissements cornéens périphériques immunologiques et dégénératifs : à propos de 10 cas. J Fr Ophtalmol 2009. [DOI: 10.1016/s0181-5512(09)73433-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
41
|
Brousseau B, Delcampe A, Gueudry J, Vera L, Doan S, Hoang-Xuan T, Muraine M. 319 Amélioration de la qualité de vie des patients atteints de Syndrome de Lyell ou de Steven-Johnson après adaptation de lentilles sclérales perméables. J Fr Ophtalmol 2009. [DOI: 10.1016/s0181-5512(09)73442-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
42
|
Alessi G, Doan S, Ltief Y, Gabison E, Papo T, Cochereau I, Lidove O. 398 Atteintes ophtalmologiques de la maladie de Fabry. J Fr Ophtalmol 2009. [DOI: 10.1016/s0181-5512(09)73522-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
43
|
Lemarinel B, Gabison E, Doan S, Teyssot N, Hoang-Xuan T. Intérêt de l’angiographie de segment antérieur au vert d’indocyanine dans la prise en charge des sclérites antérieures : à propos de 5 cas et revue de la littérature. J Fr Ophtalmol 2008; 31:495-501. [DOI: 10.1016/s0181-5512(08)72466-5] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
44
|
Brousseau B, Delcampe A, Gueudry J, Laroche J, Brasseur G, Doan S, Hoang-Xuan T, Muraine M. 322 Indication des verres scléraux perméables à l’oxygène. J Fr Ophtalmol 2008. [DOI: 10.1016/s0181-5512(08)70919-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
|
45
|
Gabison E, Doan S, Abitbol O, Hoang-Xuan T. 269 Kératites herpétiques multi récidivantes : mauvaise observance, corticodépendance ou résistance à l’acyclovir ? À propos de 15 cas. J Fr Ophtalmol 2008. [DOI: 10.1016/s0181-5512(08)70866-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
|
46
|
Doan S, Mgaieth K, Abitbol O, Gatinel D, Hoang-Xuan T, Gabison E. 287 Atopie et kératoconjonctivite vernale. J Fr Ophtalmol 2008. [DOI: 10.1016/s0181-5512(08)70884-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
47
|
Streho M, Gabison E, Abitbol O, Gatinel D, Hoang-Xuan T, Doan S. 626 Blépharite séborrhéique sévère avec complications cornéennes chez 2 patients séropositifs pour le VIH sous trithérapie anti-rétrovirale. J Fr Ophtalmol 2008. [DOI: 10.1016/s0181-5512(08)71225-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
|
48
|
Bremond-Gignac D, Donadieu J, Leonardi A, Pouliquen P, Doan S, Chiambarretta F, Montan P, Milazzo S, Hoang-Xuan T, Baudouin C, Aymé S. Prevalence of vernal keratoconjunctivitis: a rare disease? Br J Ophthalmol 2008; 92:1097-102. [PMID: 18356259 DOI: 10.1136/bjo.2007.117812] [Citation(s) in RCA: 77] [Impact Index Per Article: 4.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
Abstract
OBJECTIVE To determine the prevalence of vernal keratoconjuntivitis (VKC) in Europe. METHODS A cross-sectional survey was mailed to 3003 ophthalmologists from six countries (Finland, France, Italy, The Netherlands, Norway and Sweden) representing 151.9 million inhabitants. Results were analysed per country, and VKC prevalence for the 15 European member states in 2002 was extrapolated. Six hypotheses were used: disease duration (4 or 8 years) combined with three prevalence hypotheses for non-responding ophthalmologists. RESULTS The response rate to the survey was 29.5%. The estimates of VKC prevalence in Western Europe (per 10,000 inhabitants) ranged from 1.16 to 10.55. The prevalence of VKC with corneal complications ranged from 0.30 to 2.26. The VKC prevalences per country were in the following ranges: Italy 2.4-27.8, Finland, 0.7-8.4, Sweden 1.2-8.7, The Netherlands 0.6-4.6, France 0.7-3.3 and Norway 0.3-1.9. VKC with corneal complications were: Italy 0.4-4.8, Sweden 0.3-2.4, Finland 0.2-2.8, The Netherlands 0.2-1.6, France 0.3-1.4 and Norway 0.1-1.0. CONCLUSIONS Based on the most likely hypotheses concerning disease duration and non-responding ophthalmologists' VKC case rate, the best estimate of VKC prevalence in Western Europe is 3.2/10,000 inhabitants. The prevalence of VKC with corneal complications is 0.8/10,000 inhabitants.
Collapse
Affiliation(s)
- D Bremond-Gignac
- Service d'Ophtalmologie, Hôpital Robert Debré, APHP, 48 boulevard Sérurier, 75019 Paris, France.
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
49
|
Doan S, Gabison E, Abitbol O, Gatinel D, Chast F, Hoang-Xuan T. [Efficacy of topical 2% cyclosporine A as a steroid-sparing agent in steroid-dependent vernal keratoconjunctivitis]. J Fr Ophtalmol 2007; 30:697-701. [PMID: 17878822 DOI: 10.1016/s0181-5512(07)91357-1] [Citation(s) in RCA: 17] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
Abstract
INTRODUCTION Vernal keratoconjunctivitis (VKC) is responsible for severe conjunctival and corneal inflammation that often requires topical steroids. Steroid dependency is not rare and can lead to unacceptable complications. The aim of this study was to analyze the efficacy of 2% cyclosporine eye drops (CsA) as a steroid-sparing agent in steroid-dependent VKC. PATIENTS AND METHODS In this noncomparative interventional case series, 18 steroid-dependent VKC patients (17 males, 1 female; mean age, 13 years old) received 2% CsA qid. Topical steroids were associated at decreasing dosage for 1 week and stopped if possible. Efficacy was graded at 1 and 3 months on symptoms, signs and steroid use. Local and systemic tolerability (cyclosporinemia, creatininemia) was also assessed. RESULTS After 1 month, inflammation was controlled without steroids in 11 cases (61%). Low-dose steroids were still necessary to control the disease in four cases (22%). In three cases (17%), the disease was not controlled despite high-dose steroids. At 3 months, results were similar. All patients whose inflammation was partially controlled or not controlled by CsA had active extraocular atopic diseases. Local and systemic tolerability was excellent. CONCLUSIONS Topical 2% cyclosporine is inconstantly effective in steroid-dependent VKC. However, this treatment allows for a partial or total reduction of steroids in most cases.
Collapse
Affiliation(s)
- S Doan
- Service d'Ophtalmologie, Hôpital Bichat Claude-Bernard et Fondation A de Rothschild, Paris, France.
| | | | | | | | | | | |
Collapse
|
50
|
Bouden J, Doan S, Gabison E, Abitbol O, Gatinel D, Hoang-Xuan T. 509 Qualité de vie et kératoconjonctivite vernale. J Fr Ophtalmol 2007. [DOI: 10.1016/s0181-5512(07)80322-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|